Loading...
Chemical structure of Hetrombopag

GC69221

Hetrombopag

Also known as 5-[2-hydroxy-3-[[3-methyl-5-oxo-1-(5,6,7,8-tetrahydronaphthalen-2-yl)-4H-pyrazol-4-yl]diazenyl]phenyl]furan-2-carboxylic acid

Hetrombopag is an effective thrombopoietin receptor agonist· It is both effective and well-tolerated, with controllable safety· Hetrombopag has the potential for research in immune thrombocytopenia

ChemicalCAS2114365-78-3MW458.47FormulaC25H22N4O5
CAS number
2114365-78-3
Molecular weight
458.47
Formula
C25H22N4O5
Solubility
DMSO ： 5 mg/mL (10·91 mM; ultrasonic and warming and heat to 60°C)
InChIKey
WTZFEDHEXDVDRO-UHFFFAOYSA-N
Catalogue number
GC69221
Brand
GLPBIO
Computed properties PubChem CID 163408762 · XLogP 4.9 · TPSA 128 Ų · H-bond donors 2
XLogP
4.9
TPSA
128 Ų
H-bond donors
2
H-bond acceptors
8
Rotatable bonds
5
Heavy atoms
34

SMILES CC1=NN(C(=O)C1N=NC2=CC=CC(=C2O)C3=CC=C(O3)C(=O)O)C4=CC5=C(CCCC5)C=C4

Computed descriptors from PubChem (CID 163408762), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.